Floatz logo

FLUOROURACILUM

MSS

Sixth Affiliated Hospital, Sun Yat-sen UniversitySmall moleculePhase 3Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
81/ 100

Competitive context

21 Active assets in the MSS cohort.

Asset / SponsorPhaseRating
Eloxatin
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Irinotecan
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Calcium folinate pentahydrate
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Cetuximab
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
(+)-VINCRISTINE
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B

View all 29 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →